Related Experiment Video

Updated: May 18, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Does warfarin help prevent ischemic stroke in patients presenting with post coronary bypass paroxysmal atrial

Mitsumasa Hata1, Kenji Akiyama, Shinji Wakui

  • 1Department of Cardiovascular Surgery, Nihon University Nerima Hikarigaoka Hospital, Tokyo, Japan. hata.mitsumasa@nihon-u.ac.jp

Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
|September 14, 2012
PubMed

Insights

Warfarin combined with antiplatelet therapy significantly reduces ischemic stroke risk in patients with paroxysmal atrial fibrillation after coronary artery bypass grafting. This combination therapy is crucial for stroke prevention in this high-risk group.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Postoperative atrial fibrillation (AF) is a common complication after coronary artery bypass grafting (CABG).
  • Paroxysmal atrial fibrillation (PAF) increases the risk of ischemic stroke.
  • Effective anticoagulation strategies are needed to prevent stroke in patients with post-CABG PAF.

Purpose of the Study:

  • To evaluate the efficacy of warfarin in preventing ischemic stroke in patients experiencing paroxysmal atrial fibrillation (PAF) post-coronary artery bypass grafting (CABG).

Main Methods:

  • A cohort of 447 patients undergoing CABG with postoperative PAF was analyzed.
  • Group I (93 patients) received dual antiplatelet agents.
  • Group II (58 patients) received a single antiplatelet agent plus warfarin.
  • Outcomes compared included CHADS2 score, ischemic stroke incidence, and stroke risk factors.

Main Results:

  • Group II (warfarin + single antiplatelet) had a significantly lower incidence of ischemic stroke (1.7%) compared to Group I (dual antiplatelets) (12.9%).
  • Absence of warfarin therapy was identified as a significant risk factor for post-CABG stroke in patients with PAF (Odds Ratio 13.04).

Conclusions:

  • Concomitant warfarin and antiplatelet therapy dramatically reduces ischemic stroke incidence in patients with post-CABG PAF.
  • Warfarin is a critical component in preventing stroke in this patient population.
Abstract

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...